Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 4/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.30 |
| ▸ | CHRNA1 | P02708 | 3/20 | 0.30 |
| ▸ | CHRNG | P07510 | 3/20 | 0.30 |
| ▸ | CHRNB1 | P11230 | 3/20 | 0.30 |
| ▸ | CHRND | Q07001 | 3/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | CHRNE | Q04844 | 1/20 | 0.30 |
| ▸ | CHRNA2 | Q15822 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25128703 | 0.64 | — | — | |
| SCHEMBL31096395 | 0.64 | — | — | |
| SCHEMBL30688455 | 0.64 | — | — | |
| SCHEMBL2386824 | 0.64 | — | — | |
| SCHEMBL1496237 | 0.64 | — | — | |
| SCHEMBL23267825 | 0.62 | LIPA (0.37) | — | |
| SCHEMBL23256057 | 0.62 | LIPA (0.37) | — | |
| SCHEMBL23266167 | 0.62 | LIPA (0.37) | — | |
| SCHEMBL22591947 | 0.61 | — | — | |
| SCHEMBL23330023 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020065408-A1 | SULFOMALEIMIDE-BASED LINKERS AND CORRESPONDING CONJUGATES | PIERRE FABRE MEDICAMENT (FR) | 2020-04-02 | — | — | WO | disclosed |